|
Volumn 82, Issue 4, 2014, Pages 368-370
|
Clinical/scientific notes
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CARBAMAZEPINE;
POTASSIUM CHANNEL KCNQ2;
ANTICONVULSIVE AGENT;
BRAIN DISEASE;
ELECTROENCEPHALOGRAPHY;
EPILEPSY;
FAMILY HISTORY;
FOLLOW UP;
GENE MUTATION;
GENETIC SCREENING;
HUMAN;
INTRACTABLE EPILEPSY;
KCNQ2 ENCEPHALOPATHY;
MEDICAL RECORD REVIEW;
MENTAL DEFICIENCY;
MISSENSE MUTATION;
MOTOR DYSFUNCTION;
MUSCLE HYPERTONIA;
NEUROIMAGING;
NEUROLOGIC EXAMINATION;
NEWBORN PERIOD;
NOTE;
NUCLEAR MAGNETIC RESONANCE IMAGING;
OXYGEN THERAPY;
PHENOTYPE;
PRIORITY JOURNAL;
QUADRIPLEGIA;
RESPIRATORY FAILURE;
SEIZURE;
TREATMENT RESPONSE;
ARTICLE;
BENIGN CHILDHOOD EPILEPSY;
FEMALE;
GENETICS;
GESTATIONAL AGE;
INFANT;
MALE;
MUTATION;
PSYCHOMOTOR DISORDER;
ANTICONVULSANTS;
ELECTROENCEPHALOGRAPHY;
EPILEPSY, BENIGN NEONATAL;
FEMALE;
GESTATIONAL AGE;
HUMANS;
INFANT;
KCNQ2 POTASSIUM CHANNEL;
MAGNETIC RESONANCE IMAGING;
MALE;
MOTOR SKILLS DISORDERS;
MUTATION;
PHENOTYPE;
|
EID: 84895767176
PISSN: 00283878
EISSN: 1526632X
Source Type: Journal
DOI: 10.1212/WNL.0000000000000060 Document Type: Note |
Times cited : (110)
|
References (7)
|